Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

HEx: A heterologous expression platform for the discovery of fungal natural products.

Harvey CJB, Tang M, Schlecht U, Horecka J, Fischer CR, Lin HC, Li J, Naughton B, Cherry J, Miranda M, Li YF, Chu AM, Hennessy JR, Vandova GA, Inglis D, Aiyar RS, Steinmetz LM, Davis RW, Medema MH, Sattely E, Khosla C, St Onge RP, Tang Y, Hillenmeyer ME.

Sci Adv. 2018 Apr 11;4(4):eaar5459. doi: 10.1126/sciadv.aar5459. eCollection 2018 Apr.

2.

Streamlined circular proximity ligation assay provides high stringency and compatibility with low-affinity antibodies.

Jalili R, Horecka J, Swartz JR, Davis RW, Persson HHJ.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E925-E933. doi: 10.1073/pnas.1718283115. Epub 2018 Jan 16.

PMID:
29339495
3.

Engineering the biocatalytic selectivity of iridoid production in Saccharomyces cerevisiae.

Billingsley JM, DeNicola AB, Barber JS, Tang MC, Horecka J, Chu A, Garg NK, Tang Y.

Metab Eng. 2017 Nov;44:117-125. doi: 10.1016/j.ymben.2017.09.006. Epub 2017 Sep 20.

PMID:
28939278
4.

A method for high-throughput production of sequence-verified DNA libraries and strain collections.

Smith JD, Schlecht U, Xu W, Suresh S, Horecka J, Proctor MJ, Aiyar RS, Bennett RA, Chu A, Li YF, Roy K, Davis RW, Steinmetz LM, Hyman RW, Levy SF, St Onge RP.

Mol Syst Biol. 2017 Feb 13;13(2):913. doi: 10.15252/msb.20167233.

5.

Ndt80 activates the meiotic ORC1 transcript isoform and SMA2 via a bi-directional middle sporulation element in Saccharomyces cerevisiae.

Xie B, Horecka J, Chu A, Davis RW, Becker E, Primig M.

RNA Biol. 2016 Sep;13(9):772-82. doi: 10.1080/15476286.2016.1191738. Epub 2016 Jun 30.

6.

Rapid, Antibody-Free Detection of Recombinant Proteins on Blots Using Enzyme Fragment Complementation.

Charter NW, Horecka J, Loh CY, Doan A, Wehrman T, Olson KR.

Methods Mol Biol. 2015;1314:51-61. doi: 10.1007/978-1-4939-2718-0_7.

PMID:
26139254
7.

Integrated RNA- and protein profiling of fermentation and respiration in diploid budding yeast provides insight into nutrient control of cell growth and development.

Becker E, Liu Y, Lardenois A, Walther T, Horecka J, Stuparevic I, Law MJ, Lavigne R, Evrard B, Demougin P, Riffle M, Strich R, Davis RW, Pineau C, Primig M.

J Proteomics. 2015 Apr 24;119:30-44. doi: 10.1016/j.jprot.2015.01.015. Epub 2015 Feb 4.

8.

The conserved histone deacetylase Rpd3 and its DNA binding subunit Ume6 control dynamic transcript architecture during mitotic growth and meiotic development.

Lardenois A, Stuparevic I, Liu Y, Law MJ, Becker E, Smagulova F, Waern K, Guilleux MH, Horecka J, Chu A, Kervarrec C, Strich R, Snyder M, Davis RW, Steinmetz LM, Primig M.

Nucleic Acids Res. 2015 Jan;43(1):115-28. doi: 10.1093/nar/gku1185. Epub 2014 Dec 3.

9.

The 50:50 method for PCR-based seamless genome editing in yeast.

Horecka J, Davis RW.

Yeast. 2014 Mar;31(3):103-12. doi: 10.1002/yea.2992. Epub 2013 Dec 13.

10.

IpO: plasmids and methods for simplified, PCR-based DNA transplant in yeast.

Horecka J, Chu AM, Davis RW.

Yeast. 2014 May;31(5):185-93. doi: 10.1002/yea.3006. Epub 2014 Mar 20.

11.

Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis.

Chang ST, Zahn JM, Horecka J, Kunz PL, Ford JM, Fisher GA, Le QT, Chang DT, Ji H, Koong AC.

J Transl Med. 2009 Dec 11;7:105. doi: 10.1186/1479-5876-7-105.

12.

Rapid, antibody-free detection of recombinant proteins on blots using enzyme fragment complementation.

Charter NW, Horecka J, Loh CY, Doan A, Wehrman T, Olson KR.

Methods Mol Biol. 2009;536:395-405. doi: 10.1007/978-1-59745-542-8_40.

PMID:
19378077
13.

Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.

Fredriksson S, Horecka J, Brustugun OT, Schlingemann J, Koong AC, Tibshirani R, Davis RW.

Clin Chem. 2008 Mar;54(3):582-9. doi: 10.1373/clinchem.2007.093195. Epub 2008 Jan 2.

14.

Antibody-free method for protein detection on blots using enzyme fragment complementation.

Horecka J, Charter NW, Bosano BL, Fung P, Kobel P, Peng K, Eglen RM.

Biotechniques. 2006 Mar;40(3):381-3. No abstract available.

PMID:
16568826
15.

Homogeneous assays for cellular protein degradation using beta-galactosidase complementation: NF-kappaB/IkappaB pathway signaling.

Zhao X, Vainshtein I, Gellibolian R, Shu Y, Dotimas H, Wang XM, Fung P, Horecka J, Bosano BL, Eglen RM.

Assay Drug Dev Technol. 2003 Dec;1(6):823-33.

PMID:
15090228
16.

RAM: a conserved signaling network that regulates Ace2p transcriptional activity and polarized morphogenesis.

Nelson B, Kurischko C, Horecka J, Mody M, Nair P, Pratt L, Zougman A, McBroom LD, Hughes TR, Boone C, Luca FC.

Mol Biol Cell. 2003 Sep;14(9):3782-803. Epub 2003 May 29.

17.

The eukaryotic two-component histidine kinase Sln1p regulates OCH1 via the transcription factor, Skn7p.

Li S, Dean S, Li Z, Horecka J, Deschenes RJ, Fassler JS.

Mol Biol Cell. 2002 Feb;13(2):412-24.

19.

TRAPP I implicated in the specificity of tethering in ER-to-Golgi transport.

Sacher M, Barrowman J, Wang W, Horecka J, Zhang Y, Pypaert M, Ferro-Novick S.

Mol Cell. 2001 Feb;7(2):433-42.

20.

Use of imidazoleglycerolphosphate dehydratase (His3) as a biological reporter in yeast.

Horecka J, Sprague GF Jr.

Methods Enzymol. 2000;326:107-19. No abstract available.

PMID:
11036637
21.

Defects in protein glycosylation cause SHO1-dependent activation of a STE12 signaling pathway in yeast.

Cullen PJ, Schultz J, Horecka J, Stevenson BJ, Jigami Y, Sprague GF Jr.

Genetics. 2000 Jul;155(3):1005-18.

22.
23.
24.

Human CPR (cell cycle progression restoration) genes impart a Far- phenotype on yeast cells.

Edwards MC, Liegeois N, Horecka J, DePinho RA, Sprague GF Jr, Tyers M, Elledge SJ.

Genetics. 1997 Nov;147(3):1063-76.

26.
28.

Genetic mapping of STE20 to the left arm of chromosome VIII.

Horecka J, Sprague GF Jr.

Yeast. 1994 May;10(5):693-5.

PMID:
7941753
29.

Isolation of a conditional suppressor of leucine auxotrophy in Saccharomyces cerevisiae.

Heinemann JA, Ankenbauer RG, Horecka J.

Microbiology. 1994 Jan;140 ( Pt 1):145-52.

PMID:
8162183
30.

The yeast pheromone response pathway: new insights into signal transmission.

Ferguson B, Horecka J, Printen J, Schultz J, Stevenson BJ, Sprague GF Jr.

Cell Mol Biol Res. 1994;40(3):223-8.

PMID:
7874199
31.

Cis- and trans-acting functions required for endocytosis of the yeast pheromone receptors.

Davis NG, Horecka JL, Sprague GF Jr.

J Cell Biol. 1993 Jul;122(1):53-65.

32.

FAR1 links the signal transduction pathway to the cell cycle machinery in yeast.

Peter M, Gartner A, Horecka J, Ammerer G, Herskowitz I.

Cell. 1993 May 21;73(4):747-60.

PMID:
8500168
33.

A complex of nuclear pore proteins required for pore function.

Finlay DR, Meier E, Bradley P, Horecka J, Forbes DJ.

J Cell Biol. 1991 Jul;114(1):169-83.

34.

[Clinical problems in non-A, non-B viral hepatitis. III. The course of non-A, non-B viral hepatitis in the chronic stages].

Jezek P, Chalupa P, Horecká J, Kolácný I, Horák Z.

Vnitr Lek. 1990 Dec;36(12):1158-63. Czech.

PMID:
2126648
35.

Nuclear transport in vitro.

Finlay DR, Newmeyer DD, Hartl PM, Horecka J, Forbes DJ.

J Cell Sci Suppl. 1989;11:225-42.

PMID:
2613752
36.

[Use of the radiosaturation analysis method in the diagnosis and monitoring of viral hepatitis].

Horák Z, Jezek P, Kolácný I, Horecká J, Chalupa P.

Cesk Radiol. 1986 May;40(3):190-4. Czech. No abstract available.

PMID:
3087635
37.

[The ratio of urea nitrogen to total urinary nitrogen in liver diseases].

Dastych M, Horecká J, Parák S, Snelerová M.

Cas Lek Cesk. 1984 Aug 17;123(33):1024-6. Czech. No abstract available.

PMID:
6498890
38.

[Nitrogen balance in viral hepatitis B].

Dastych M, Horecká J.

Vnitr Lek. 1984 Aug;30(8):745-50. Czech. No abstract available.

PMID:
6506496
39.

[Incidence and dynamics of circulating immune complexes in acute viral hepatitis HBsAg positive and negative (author's transl)].

Pintera J, Jezek P, Horecká J, Krajcová M.

Cas Lek Cesk. 1981 Apr 30;120(17):513-7. Czech. No abstract available.

PMID:
7237498
40.

[Dynamics examination of eliminating surface antigen of Hepatitis B Virus (HBsAg) and its significance for the prognosis of the disease and the carrier state (author's transl)].

Pejcochová J, Jandásek L, Jezek P, Horecká J.

Cesk Epidemiol Mikrobiol Imunol. 1978 Apr;27(2):79-83. Czech. No abstract available.

PMID:
149606
41.

[Changes of serum acetoin level in patients with liver diseases after intravenous administration of alpha-lipoic acid].

Jezek P, Horecká J.

Cas Lek Cesk. 1975 Nov 7;114(45):1389-92. Czech. No abstract available.

PMID:
1106854
42.

[Experiences in the determination of hepatitis B antigen in acute viral hepatitis].

Houbal V, Jezek P, Horecká J.

Vnitr Lek. 1975 Jan;21(1):40-4. Czech.

PMID:
803327
43.

[Psychic changes after hepatic coma (author's transl)].

Horecká J, Mandlová I, Misurec J, Sláma B, Jezek P.

Cesk Gastroenterol Vyz. 1973 Dec;27(8):514-20. Czech. No abstract available.

PMID:
4769623
44.

[Serum levels of immunoglobulins IgG, IgA and transferin and importance of the ratio IgA-transferin in patients with liver diseases (author's transl)].

Kratochvil F, Horecká J.

Cesk Gastroenterol Vyz. 1973 Oct;27(7):448-53. Czech. No abstract available.

PMID:
4760007
45.

[Changes in blood acetoin levels in patients with hepatic diseases. II. Changes in blood acetoin after administration of glucose].

Jezek P, Houbal V, Horecká J, Parák S.

Cas Lek Cesk. 1972 Jun 23;111(27):617-20. Czech. No abstract available.

PMID:
5036906
46.

[Changes in serum acetoin level in patients with liver diseases].

Jezek P, Houbal V, Horecká J, Parák S, Rysánek K.

Cas Lek Cesk. 1970 Mar 13;109(13):269-73. Czech. No abstract available.

PMID:
5438775
47.

[Clinical significance of positive SGOT screening test in blood donors].

Pintera J, Valnícek S, Vacl J, Horecká J, Králícková J.

Vnitr Lek. 1969 Sep;15(9):881-6. Czech. No abstract available.

PMID:
5824799
48.

A new screening test for the activity of serum glutamic oxalacetic transaminase in blood donors performed before blood collection.

Pintera J, Valnícek S, Vacl J, Horecká J, Králícková J.

Blut. 1969 Jul;19(4):226-31. No abstract available.

PMID:
5793732
49.

[On lysozyme activity in the serum of patients with infectious hepatitis].

Hendrich F, Máchová L, Horecká J, Pospísil L.

Wien Med Wochenschr. 1969 Mar 22;119(12):231-3. German. No abstract available.

PMID:
5787163
50.

[Therapeutic utilization of fructose in liver diseases].

Horecká J.

Cesk Gastroenterol Vyz. 1969 Mar;23(2):74-7. Czech. No abstract available.

PMID:
5768480

Supplemental Content

Loading ...
Support Center